| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Prospective, Observational, Post-approval Registry of Inhibitor Patients Treated With Multiple or Single Doses of Recombinant Activated Factor VII
|
Chambost, Hervé
|
|
2008
|
45 |
S1 |
p. S35-S37
3 p.
|
artikel
|
| 2 |
Arthropathy in Inhibitor Patients: Differences in the Joint Status
|
Hoots, W. Keith
|
|
2008
|
45 |
S1 |
p. S42-S49
8 p.
|
artikel
|
| 3 |
Blood-Induced Joint Disease: The Confluence of Dysregulated Oncogenes, Inflammatory Signals, and Angiogenic Cues
|
Valentino, Leonard A.
|
|
2008
|
45 |
S1 |
p. S50-S57
8 p.
|
artikel
|
| 4 |
Controversies and Challenges in Elective Orthopedic Surgery in Patients With Hemophilia and Inhibitors
|
Jiménez-Yuste, Victor
|
|
2008
|
45 |
S1 |
p. S64-S67
4 p.
|
artikel
|
| 5 |
Factor VIIa Interaction With Tissue Factor and Endothelial Cell Protein C Receptor on Cell Surfaces
|
Pendurthi, Usha R.
|
|
2008
|
45 |
S1 |
p. S21-S24
4 p.
|
artikel
|
| 6 |
Further Understanding of Recombinant Activated Factor VII Mode of Action
|
Monroe, Dougald M.
|
|
2008
|
45 |
S1 |
p. S7-S11
5 p.
|
artikel
|
| 7 |
Introduction: Proceedings From the 9th Novo Nordisk Symposium on Haemostasis Management
|
Rodriguez-Merchan, E. Carlos
|
|
2008
|
45 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 8 |
Investing in Hemophilia Care: Benefits and Costs for Patients and Society
|
Scalone, Luciana
|
|
2008
|
45 |
S1 |
p. S31-S34
4 p.
|
artikel
|
| 9 |
Monitoring Inhibitor Patients With the Right Assays
|
Barrowcliffe, Trevor W.
|
|
2008
|
45 |
S1 |
p. S25-S30
6 p.
|
artikel
|
| 10 |
On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers
|
Carcao, Manuel D.
|
|
2008
|
45 |
S1 |
p. S68-S71
4 p.
|
artikel
|
| 11 |
Orthopedic Management in Hemophilia: A Spanish Outlook
|
Rodriguez-Merchan, E. Carlos
|
|
2008
|
45 |
S1 |
p. S58-S63
6 p.
|
artikel
|
| 12 |
Platelet Tissue Factor: How Did It Get There and Is It Important?
|
Key, Nigel S.
|
|
2008
|
45 |
S1 |
p. S16-S20
5 p.
|
artikel
|
| 13 |
Safety Update on Recombinant Factor VIIa in the Treatment of Congenital and Acquired Hemophilia
|
Abshire, Thomas
|
|
2008
|
45 |
S1 |
p. S3-S6
4 p.
|
artikel
|
| 14 |
Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors
|
Kenet, Gili
|
|
2008
|
45 |
S1 |
p. S38-S41
4 p.
|
artikel
|
| 15 |
Successful Control of Central Nervous System Bleeding in Two Newborns With Severe Factor VII Deficiency Using rFVIIa Administered via Port-a-Cath
|
Karimi, Mehran
|
|
2008
|
45 |
S1 |
p. S74-
1 p.
|
artikel
|
| 16 |
Supplement Disclaimer
|
|
|
2008
|
45 |
S1 |
p. A3-
1 p.
|
artikel
|
| 17 |
Suppl Masthead
|
|
|
2008
|
45 |
S1 |
p. IFC-
1 p.
|
artikel
|
| 18 |
Suppl TOC
|
|
|
2008
|
45 |
S1 |
p. A1-A2
nvt p.
|
artikel
|
| 19 |
Tissue Factor–Independent Effects of Recombinant Factor VIIa on Hemostasis
|
Weeterings, Cees
|
|
2008
|
45 |
S1 |
p. S12-S15
4 p.
|
artikel
|
| 20 |
Use of the Thrombin Generation Test to Evaluate Response to Treatment With Recombinant Activated Factor VII
|
Dargaud, Yesim
|
|
2008
|
45 |
S1 |
p. S72-S73
2 p.
|
artikel
|
Tijdschrift beschrijving